Trial intelligence / Profile preview

Scandinavian Cystic Fibrosis Azithromycin Study

2006-003275-12Phase 4Completed

Sponsor
Copenhagen Cystic Fibrosis Centre
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cystic fibrosis (CF) comparing Azithromycin arm with Placebo arm (2 arms). Primary endpoint: Time to next appearance of Pseudomonas aeruginosa in sputum samples. Started Apr 2007; status: completed.

02

Drugs

azithromycin
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on 2006-003275-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003275-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call